The seasonal influenza vaccine Agriflu ®

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Seasonal influenza continues to have a large impact annually. Combined with pneumonia, influenza is the sixth leading cause of death in the USA, and vaccination has been the most important tool to prevent it. Agriflu ® is an egg-derived, subunit, nonadjuvanted trivalent inactivated vaccine indicated for immunization to prevent disease caused by influenza virus subtypes A and B contained in the vaccine. Agriflu was approved in the USA by the US FDA on 27 November 2009, for those aged 18 years and older, to prevent disease caused by influenza virus subtypes A and B. Based on clinical trial evidence, Agriflu has been shown to be safe, with ®, Agriflu is the only subunit vaccine available in the USA. Owing to the economic burden, morbidity and mortality caused by seasonal influenza, addition of new, safe and effective vaccines to the available tools, to reduce the impact of influenza, is of importance and benefit, especially in the face of the recent shortages of influenza vaccines.

Original languageEnglish
Pages (from-to)1513-1517
Number of pages5
JournalExpert Review of Vaccines
Volume10
Issue number11
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Influenza Vaccines
Human Influenza
Influenza B virus
Influenza A virus
Vaccines
Inactivated Vaccines
Subunit Vaccines
Ovum
Cause of Death
Immunization
Pneumonia
Vaccination
Economics
Clinical Trials
Morbidity
Mortality

Keywords

  • egg derived
  • immunogenicity
  • inactivated
  • influenza
  • safety
  • subunit
  • trivalent
  • vaccination

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

The seasonal influenza vaccine Agriflu ® . / Vajó, Z.

In: Expert Review of Vaccines, Vol. 10, No. 11, 11.2011, p. 1513-1517.

Research output: Contribution to journalArticle

@article{a586bcab2db24ac3a1336b30e222dd57,
title = "The seasonal influenza vaccine Agriflu {\circledR}",
abstract = "Seasonal influenza continues to have a large impact annually. Combined with pneumonia, influenza is the sixth leading cause of death in the USA, and vaccination has been the most important tool to prevent it. Agriflu {\circledR} is an egg-derived, subunit, nonadjuvanted trivalent inactivated vaccine indicated for immunization to prevent disease caused by influenza virus subtypes A and B contained in the vaccine. Agriflu was approved in the USA by the US FDA on 27 November 2009, for those aged 18 years and older, to prevent disease caused by influenza virus subtypes A and B. Based on clinical trial evidence, Agriflu has been shown to be safe, with {\circledR}, Agriflu is the only subunit vaccine available in the USA. Owing to the economic burden, morbidity and mortality caused by seasonal influenza, addition of new, safe and effective vaccines to the available tools, to reduce the impact of influenza, is of importance and benefit, especially in the face of the recent shortages of influenza vaccines.",
keywords = "egg derived, immunogenicity, inactivated, influenza, safety, subunit, trivalent, vaccination",
author = "Z. Vaj{\'o}",
year = "2011",
month = "11",
doi = "10.1586/erv.11.133",
language = "English",
volume = "10",
pages = "1513--1517",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - The seasonal influenza vaccine Agriflu ®

AU - Vajó, Z.

PY - 2011/11

Y1 - 2011/11

N2 - Seasonal influenza continues to have a large impact annually. Combined with pneumonia, influenza is the sixth leading cause of death in the USA, and vaccination has been the most important tool to prevent it. Agriflu ® is an egg-derived, subunit, nonadjuvanted trivalent inactivated vaccine indicated for immunization to prevent disease caused by influenza virus subtypes A and B contained in the vaccine. Agriflu was approved in the USA by the US FDA on 27 November 2009, for those aged 18 years and older, to prevent disease caused by influenza virus subtypes A and B. Based on clinical trial evidence, Agriflu has been shown to be safe, with ®, Agriflu is the only subunit vaccine available in the USA. Owing to the economic burden, morbidity and mortality caused by seasonal influenza, addition of new, safe and effective vaccines to the available tools, to reduce the impact of influenza, is of importance and benefit, especially in the face of the recent shortages of influenza vaccines.

AB - Seasonal influenza continues to have a large impact annually. Combined with pneumonia, influenza is the sixth leading cause of death in the USA, and vaccination has been the most important tool to prevent it. Agriflu ® is an egg-derived, subunit, nonadjuvanted trivalent inactivated vaccine indicated for immunization to prevent disease caused by influenza virus subtypes A and B contained in the vaccine. Agriflu was approved in the USA by the US FDA on 27 November 2009, for those aged 18 years and older, to prevent disease caused by influenza virus subtypes A and B. Based on clinical trial evidence, Agriflu has been shown to be safe, with ®, Agriflu is the only subunit vaccine available in the USA. Owing to the economic burden, morbidity and mortality caused by seasonal influenza, addition of new, safe and effective vaccines to the available tools, to reduce the impact of influenza, is of importance and benefit, especially in the face of the recent shortages of influenza vaccines.

KW - egg derived

KW - immunogenicity

KW - inactivated

KW - influenza

KW - safety

KW - subunit

KW - trivalent

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=80455158310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455158310&partnerID=8YFLogxK

U2 - 10.1586/erv.11.133

DO - 10.1586/erv.11.133

M3 - Article

C2 - 22043951

AN - SCOPUS:80455158310

VL - 10

SP - 1513

EP - 1517

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 11

ER -